Answer
Zanubrutinib (Brukinsa) should not be used during pregnancy because animal studies show reproductive toxicity and potential foetal harm, and there are no data on its use in pregnant women.
Sources for this answer
- BRUKINSA 80 mg hard capsulesBeOne Medicines UK, Ltd. · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked